Relationship between postrenal transplant osteonecrosis of the femoral head and gene polymorphisms related to the coagulation and fibrinolytic systems in Japanese subjects

被引:87
作者
Asano, T
Takahashi, KA [1 ]
Fujioka, M
Inoue, S
Ueshima, K
Hirata, T
Okamoto, M
Satomi, Y
Nishino, H
Tanaka, T
Hirota, Y
Kubo, T
机构
[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kamigyo Ku, Kyoto 6028566, Japan
[2] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Transplantat & Regenerat Surg, Kyoto, Japan
[3] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Biochem & Mol Biol, Kyoto, Japan
[4] Osaka City Univ, Fac Med, Dept Publ Hlth, Osaka 558, Japan
关键词
D O I
10.1097/01.TP.0000101433.99651.96
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Background. Nontraumatic osteonecrosis of the femoral head (ONFH) is one of the complications that may occur after renal transplantation. We investigated the relationship between the incidence of ONFH and polymorphisms in the genes for plasminogen activator inhibitor (PAI)-1, which is one of the major regulatory proteins of the fibrinolytic system, and 5,10-methylenetetrahydrofolate reductase (MTHFR), which is associated with the plasma levels of homocysteine in Japanese subjects. Methods. Thirty-one patients with postrenal transplant ONFH and 106 patients without ONFH were selected. Genotypes of PAI-1 4G/5G and MTHFR C677T were determined by direct sequencing of genomic DNA. In addition, plasma PAI-1 antigen (Ag) levels and plasma total homocysteine (tHcy) levels at the steady state were measured. The relationships between the incidence of ONFH and these genotypes, as well as plasma levels of the gene products, were investigated. Results. Plasma PAI-1 Ag levels were the highest in patients with the 4G/4G genotype, and plasma tHcy levels were the highest in patients with TT genotypes of MTHFR C677T. However, the relationship between the incidence of ONFHH and PAI-1 4G/5G or MTHFR C677T was not observed. The relationship between the incidence of ONFH and plasma levels of PAI-1 Ag or tHcy was not observed. Conclusions. Genotypes of PAI-1 4G/5G and MTHFR C677T or plasma concentrations of PAI-1 Ag and tHcy had no effect on the incidence of ONFH in Japanese subjects, unlike the results of studies performed in white subjects. The effect of genetic background on the pathologic conditions that developed in patients with postrenal transplant ONFH may differ according to race.
引用
收藏
页码:220 / 225
页数:6
相关论文
共 29 条
[1]
DETERMINATION OF FREE AND TOTAL HOMOCYSTEINE IN HUMAN-PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION [J].
ARAKI, A ;
SAKO, Y .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 422 :43-52
[2]
Determinants of fasting plasma total homocysteine levels among chronic stable renal transplant recipients [J].
Bostom, AG ;
Gohh, RY ;
Beulieu, AJ ;
Han, H ;
Jacques, PF ;
Selhub, J ;
Dworkin, L ;
Rosenberg, IH .
TRANSPLANTATION, 1999, 68 (02) :257-261
[3]
DAWSON SJ, 1993, J BIOL CHEM, V268, P10739
[4]
Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients [J].
Ferrari, P ;
Schroeder, V ;
Anderson, S ;
Kocovic, L ;
Vogt, B ;
Schiesser, D ;
Marti, HP ;
Ganz, R ;
Frey, FJ ;
Kohler, HP .
TRANSPLANTATION, 2002, 74 (08) :1147-1152
[5]
A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113
[6]
Glueck CJ, 2001, CLIN ORTHOP RELAT R, P19
[7]
Glueck CJ, 1999, CLIN ORTHOP RELAT R, P133
[8]
Glueck CJ, 1997, CLIN ORTHOP RELAT R, P43
[9]
Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (<= 40 mu mol/liter) - The Hordaland homocysteine study [J].
Guttormsen, AB ;
Ueland, PM ;
Nesthus, I ;
Nygard, O ;
Schneede, J ;
Vollset, SE ;
Refsum, H .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (09) :2174-2183
[10]
Bone disease after renal transplantation [J].
Heaf, JG .
TRANSPLANTATION, 2003, 75 (03) :315-325